Max Rady College of Medicine
Term: Therapeutic Interchange Policy
Glossary Definition
Last Updated: 2005-12-05
Definition:
Reimbursing consumers at the rate of the lowest price equivalent drug - a policy that promotes consumer's price sensitivity when selecting among both patented and non-patented products. Uses reference based pricing mechanisms, prescribing protocols, and special authority restrictions to regulate the use of higher priced chemically distinct but therapeutically similar products.
Related terms
- Prescribing Protocols
- Reference Based Pricing Policies
- Special Authority Policies
- Step-Down Approach
- Step-Up Approach
- Therapeutic Interchange
- Top-Down Costing
References
- Morgan SG, Kozyrskyj A, Metge C, Roos NP. Pharmaceuticals: Therapeutic interchange and pricing policies. Winnipeg, MB: Manitoba Centre for Health Policy, 2003. [Report] [Summary] (View)
Request information in an accessible format
If you require access to our resources in a different format, please contact us:
- by phone at 204-789-3819
- by email at info@cpe.umanitoba.ca
We strive to provide accommodations upon request in a reasonable timeframe.
Contact us
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada